Advertisement
Advertisement
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
12.39
USDSponsored
+0.04
+0.32%
Sep 18, 15:59 UTC -4
Closed
After-Market
12.37
-0.03
-0.20%
MoonLake Immunotherapeutics Class A Ordinary Shares Financial Snapshot
| Market Cap | 1.05B |
| Beta | 1.04 |
| Earnings Per Share (EPS) | -3.84 |
| Price-to-Book (P/B) Ratio | 2.41 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 23.24% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -82.53% |
| Current Ratio | 12.56% |
| Free Cash Flow | -121.84M |
